Gapping up
In reaction to strong earnings/guidance: PAL +13.7%, ASTI +12.9%, TNK +11.9%, BJRI +10.9%, BBW +7.6%, SIX +5.8%, IPAS +5.6%, (also declared its commitment to remain independent and announced Gary Griffiths as chief executive officer and Patricia Hume as the newly established position of chief commercial officer), SNPS +5.2%, SGNT +5.2%, AVG +4.5%, ATRO +4.5%,STAR +4.5%, AYR +4.1%, TRN +3.7%, TILE +3.6%, MAR +3.5%, TMUS +3.5%, NVMI +3.4%, XPO +3.1%, ABX +3.1%, DRII +2.8%, IPI +2.8%, DRII +2.8%, SCG +2.5%, TK +2.4%, ARIA +2.2%, CRMT +2%, IDA +1.8%, MIC +1.6%, UIHC +1.1%, (also following late sell-off), LOPE +1.1%, HRL +0.9%, THRX +0.8%, DTV +0.8%
M&A news: DLPH +1.9% (announces definitive agreement to sell thermal business to MAHLE)
Select airline related names showing strength: VA +2.6%, DAL +2.1%, AAL +1.8%, LUV +1.7%, UAL +1.5%, HA +1.5%, ALK +1.5%
Select metals/mining stocks trading higher: HMY +5%, KGC +3.2%, IAG +3.0%, GFI +2%, SLV +1.3%, GDX +1.3%, AG +1.3%, EGO +1.1%
Other news: TTPH +12.3% (attributed to LA Times report on 'superbug' CRE that has infected 2 residents of California), EXEL +8.1% (FDA grants EXEL and Genentech's Cobimetinib Priority Review for use in combination with Zelboraf in advanced melanoma), CAPN +7.9% (cont strength), CYTX +5.1% (cont strength), FL +1.9% (approves new $1 billion share repurchase program, a 67% increase; Approves $220 million capital expenditure program for 2015; also increases quarterly dividend to $0.25 from $0.22/share), NBG +1.3% (cont vol with Greece/Eu talks), MNKD +1.1% (following late spike)
Analyst comments: EPRS +6.1% (initiated with a Outperform at Wedbush), SNY +1.3% (upgraded to Buy from Neutral at BofA/Merrill), HOLX +1.2% (upgraded to Buy from Hold at Canaccord Genuity), COH +0.9% (upgraded to Buy from Hold at Topeka Capital Markets), RCPT +0.7% (target raised to $140 from $125 at Credit Suisse; Outperform)
In reaction to strong earnings/guidance: PAL +13.7%, ASTI +12.9%, TNK +11.9%, BJRI +10.9%, BBW +7.6%, SIX +5.8%, IPAS +5.6%, (also declared its commitment to remain independent and announced Gary Griffiths as chief executive officer and Patricia Hume as the newly established position of chief commercial officer), SNPS +5.2%, SGNT +5.2%, AVG +4.5%, ATRO +4.5%,STAR +4.5%, AYR +4.1%, TRN +3.7%, TILE +3.6%, MAR +3.5%, TMUS +3.5%, NVMI +3.4%, XPO +3.1%, ABX +3.1%, DRII +2.8%, IPI +2.8%, DRII +2.8%, SCG +2.5%, TK +2.4%, ARIA +2.2%, CRMT +2%, IDA +1.8%, MIC +1.6%, UIHC +1.1%, (also following late sell-off), LOPE +1.1%, HRL +0.9%, THRX +0.8%, DTV +0.8%
M&A news: DLPH +1.9% (announces definitive agreement to sell thermal business to MAHLE)
Select airline related names showing strength: VA +2.6%, DAL +2.1%, AAL +1.8%, LUV +1.7%, UAL +1.5%, HA +1.5%, ALK +1.5%
Select metals/mining stocks trading higher: HMY +5%, KGC +3.2%, IAG +3.0%, GFI +2%, SLV +1.3%, GDX +1.3%, AG +1.3%, EGO +1.1%
Other news: TTPH +12.3% (attributed to LA Times report on 'superbug' CRE that has infected 2 residents of California), EXEL +8.1% (FDA grants EXEL and Genentech's Cobimetinib Priority Review for use in combination with Zelboraf in advanced melanoma), CAPN +7.9% (cont strength), CYTX +5.1% (cont strength), FL +1.9% (approves new $1 billion share repurchase program, a 67% increase; Approves $220 million capital expenditure program for 2015; also increases quarterly dividend to $0.25 from $0.22/share), NBG +1.3% (cont vol with Greece/Eu talks), MNKD +1.1% (following late spike)
Analyst comments: EPRS +6.1% (initiated with a Outperform at Wedbush), SNY +1.3% (upgraded to Buy from Neutral at BofA/Merrill), HOLX +1.2% (upgraded to Buy from Hold at Canaccord Genuity), COH +0.9% (upgraded to Buy from Hold at Topeka Capital Markets), RCPT +0.7% (target raised to $140 from $125 at Credit Suisse; Outperform)